Q4 2025 Eris Lifesciences Ltd Earnings Call Transcript

May 19, 2025 / 10:30 AM GMT

Release Date Price: ₹1443.45 (-1.48%)

Transcript

Key Points

Positve

Eris Lifesciences Ltd (NSE:ERIS) reported a 28% year-on-year growth in consolidated operating revenue for Q4, reaching INR 705 crores.
The company achieved a significant 70% year-on-year growth in consolidated EBITDA, amounting to INR 252 crores.
Eris Lifesciences Ltd (NSE:ERIS) saw a 28% growth in profit after tax, totaling INR 102 crores for the quarter.
The company reported a strong operating cash flow to EBITDA ratio of 111% in Q4.
The return on capital employed (ROCE) improved to 15% for FY25, up from 11% in the previous year, with an adjusted ROCE of 20%.

Negative

There was a significant product shortage in human insulin, resulting in an estimated sales loss of around INR 50 crores.
The critical care segment experienced a planned 20% decline, attributed to delays in building out the domestic go-to-market strategy.
The company faced challenges in the oncology business due to product mix issues, impacting performance.
Insulin fill-in took longer than anticipated, affecting the rollout of certain products.
The company experienced intermittent connection issues during the earnings call, leading to unclear communication at times.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

ERIS.NS - Eris Lifesciences Ltd
Q4 2025 Eris Lifesciences Ltd Earnings Call
May 19, 2025 / 10:30AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Ladies and gentlemen, good day and welcome to the Q4 and FI 25 earnings conference call of Eris Life Sciences Limited.

We have with us on the call today Mr. Ahmed Bakshi, Chairman and managing director.

Mr. V. Krishna Kumar, Chief Operating Officer and executive director, Mr. Sachin Shah, Chief Financial Officer, and Ms. Kruti Ravi, head investor relations. As a reminder, all participant lines will be in the lesson mode, and there will be an opportunity for you to ask questions after the presentation concludes. Please note that this conference is being recorded.

I now hand the conference over to Mr. V. Krishna Kumar, chief op operating officer and executive director of the company.

Thank you

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.